Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Progenics reports topline phase III data on 1404 in low-grade prostate cancer

Sep. 13, 2018

Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints

Sep. 6, 2018

Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging

Aug. 24, 2018

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Evaluation of [11C]BU-99008 as a marker for AD pathology mechanisms

July 26, 2018

Phase 0 results presented for tau-imaging tracer [18F]JNJ-067

July 26, 2018

Synaptic vesicle glycoprotein 2A by PET imaging, a marker of synaptic density in Alzheimer's disease

July 20, 2018

Selective PDE4D PET ligands developed to study depression and cognitive impairment

July 19, 2018

Discovery of novel PET tracer for imaging CSF-1R in the brain

July 18, 2018

Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...